Weil
Alejandro David Weil, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20080256638 | SYSTEM AND METHOD FOR PROVIDING NETWORK PENETRATION TESTING - A system and method for providing network penetration testing from an end-user computer is provided. The method includes the step of determining at least one of a version of a Web browser of a target computer, contact information associated with an end-user that uses the target computer, and applications running on the target computer. The method also includes the steps of determining exploits that are associated with the running applications and that can be used to compromise the target computer, and launching the exploits to compromise the target computer. Network penetration testing may also be provided by performing the steps of determining an operating system of a target computer, selecting one of a group of modules to use in detecting services of the target computer, and detecting the services of the target computer. | 10-16-2008 |
Arnaud Weil, Beauzelle FR
Patent application number | Description | Published |
---|---|---|
20110011979 | DEVICE FOR RETRACTABLE TABLET AND SEAT - A stowable table device for a foldable seat, the seat including a first mobile portion defining a seating portion and a second portion defining the back, the mobile portion having a first folded position and a second unfolded position. The stowable table includes a plate. The device further includes an arm movably attached to the seat by one end thereof, and a linking part movably attached to the arm by the other end thereof and to the plate so that, in a stowed position, the plate is substantially located against a first surface of the mobile part of the seat independently from the position of the mobile part, and in an unfolded position, the structure is located opposite a second surface of the mobile part of the seat and substantially parallel to the second surface, the first and second surfaces of the mobile part of the sheet being substantially parallel. | 01-20-2011 |
Bernard Weil, Paris FR
Patent application number | Description | Published |
---|---|---|
20090320369 | METHOD OF GENERATING AN ENERGY SOURCE FROM A WET GAS FLOW - A method of generating energy from a gas flow, called the initial flow, including water vapour, the method including the deoxidation of at least some of the water vapour by passing the initial gas flow through a layer of material at high temperature, called the thermal base layer, essentially including high-temperature carbon, the deoxidation making it possible to obtain a first gas flow comprising hydrogen obtained by the reaction of the water vapour with the carbon elements. The initial flow may be a gas flow that has served for the treatment of a charge of wood. The hydrogen obtained constitutes an energy source and may then be used to produce energy by a gas boiler, a gas turbine, a fuel cell, a gas-powered engine, a turboalternator, or the like. | 12-31-2009 |
Daniel Weil, London GB
Patent application number | Description | Published |
---|---|---|
20110066494 | METHOD AND SYSTEM OF DISPLAYING, MANAGING AND SELLING IMAGES IN AN EVENT PHOTOGRAPHY ENVIRONMENT - A system for displaying photographs is provided. The display system includes a plurality of rotatable carousels that each possess a plurality of slots for receiving folders that hold photographs taken by an event organizer. | 03-17-2011 |
20140291272 | INFANT FEEDING BOTTLE - A feeding bottle ( | 10-02-2014 |
Dany Weil, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20130251126 | SYSTEM AND METHOD FOR SUPPORTING SELF SERVICE AND ASSOCIATED AGENT-ASSISTED SERVICE CALL ROUTING - A method and system support an interaction of a user with a self service application via a self service access terminal, which may be a mobile device. The user employs the self service access terminal to navigate a decision tree associated with the self service application. When the user reaches a point in the decision tree which indicates that an agent-assisted service session should be initiated between the user and a human agent, the voice call may be initiated and data associated with the interaction with the self service application is communicated to an agent computer which displays the data to the human agent who handles the voice call. The data may include user data, environmental data, line-of-business data pertaining to the user, and/or data indicating the path on the decision tree which the user traversed prior to the voice call. | 09-26-2013 |
Dominique Weil, Paris FR
Patent application number | Description | Published |
---|---|---|
20090104600 | Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide. | 04-23-2009 |
20110059855 | Use of adiponectin for the diagnosis and/or treatment of presbycusis - The present invention relates to mutations located within the gene coding for adiponectin, said mutations being associated with presbycusis. The present invention further relates to adiponectin polynucleotides comprising such mutations, to adiponectin polypeptides encoded by such polynucleotides, and to methods of diagnosing and/or treating presbycusis using adiponectin polynucleotides, adiponectin polypeptides and/or ADIPOR2 polypeptides. | 03-10-2011 |
20120322059 | MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide. | 12-20-2012 |
20140113285 | MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide. | 04-24-2014 |
Gérard Weil, Sainte Foy Les Lyon FR
Patent application number | Description | Published |
---|---|---|
20130338455 | DEVICE FOR MONITORING A MEDICAL PROSTHESIS AND THE HUMAN BODY - A device for monitoring a medical prosthesis and the human body includes a sensor for generating signals depending on surrounding stresses, a processor for processing the signals emitted by the sensor in order to convert the signals into data, a storage device for storing the data, a device for wireless transmission of the stored data, and a supply of electrical energy. The device is included in at least one casing, which is made of biocompatible material and has a device for fixing to a bone. | 12-19-2013 |
Gil Weil, Shoam IL
Patent application number | Description | Published |
---|---|---|
20100223193 | CARD-NOT-PRESENT FRAUD PREVENTION - A system and method for preventing card not present (CNP) fraud by a customer performing a CNP transaction with a transaction provider. The customer signature and at least one added identification input related to the transaction are provided to and stored on a dedicated server. The customer signature and added ID input are then retrieved by the transaction provider in case the customer denies the transaction, to prove that the transaction was valid. | 09-02-2010 |
Miguel Enrique Weil, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20120213769 | METHODS OF DIAGNOSING AMYOTROPHIC LATERAL SCLEROSIS (ALS) - A method of diagnosing amyotrophic lateral sclerosis (ALS) in a subject in need thereof is provided. The method comprising determining in cells of the subject at least one alteration in a sequence or expression level of Cytoplasmic FMR Interacting Protein (CyFIP2; Accession AF160973) and/or Retinoblastoma Binding Protein 9 (RbBP9; Accession AF039564), wherein an altered sequence or expression of the sequence or expression level of the CyFIP2; Accession AF160973) or Retinoblastoma Binding Protein 9 (RbBP9; Accession AF039564) as compared to a control reference sample from a non-ALS subject, is indicative of ALS. The present teachings may be implemented in screening for novel anti-ALS medicaments and for treating ALS. | 08-23-2012 |
Ofer Weil, Modi'In IL
Patent application number | Description | Published |
---|---|---|
20090077228 | Behavioral classification of communication sessions using active session initiation - A method includes measuring behavioral characteristics of a plurality of communication sessions in a communication network. A subset of the sessions is identified using the behavioral characteristics, such that the sessions in the subset are suspected of using a target communication protocol. A candidate session is selected from the subset. A trial communication session is initiated with a node of the communication network, which participates in the candidate session, using the target communication protocol. Responsively to receiving a positive response from the node to initiation of the trial communication session, it is determined that one or more further sessions in the plurality are using the target communication protocol. The one or more further sessions are controlled responsively to a predetermined control criterion that is applicable to the target communication protocol. | 03-19-2009 |
Patrick Weil, Peron FR
Patent application number | Description | Published |
---|---|---|
20100310745 | FLAVORING COMPOSITIONS FOR SAVORY APPLICATIONS - A method for conferring, enhancing, improving or modifying savory, roast or caramel notes in a flavoring composition or flavored food, by adding to the composition or food a flavour effective amount of a compound of formula (I), | 12-09-2010 |
Richard Weil, London GB
Patent application number | Description | Published |
---|---|---|
20130266150 | ACTIVE NOISE CANCELLING EAR PHONE SYSTEM - An earphone has a casing, containing a speaker, the casing being adapted to fit within the outer ear of a user at the entrance to the ear canal of the user. The casing has a guide, protruding from the front surface of the casing, and suitable for locating in the ear canal of the user. The casing is also adapted to allow sound to pass through a sound-permeable portion of the front surface. The casing has sound channels, leading across the front surface of the casing from the sound-permeable portion to a periphery of the first surface of the casing. The earphone can be used in a noise cancelling earphone system, with signal processing circuitry connected to the microphone and to the speaker, wherein the signal processing circuitry is adapted to receive the ambient noise signal from the microphone, and to apply the ambient noise signal to a filter having a controllable amount of gain, for generating a noise cancellation signal for transmission to the speaker. The result is that, however the earphone is worn within the outer ear of a user, an amount of sound leakage lies within a predetermined range, such that the amount of gain to be applied by the signal processing circuitry falls within a relatively narrow range. | 10-10-2013 |
Robert Weil, Saint-Clous FR
Patent application number | Description | Published |
---|---|---|
20090061480 | NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB - The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB. | 03-05-2009 |
20100144615 | NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB - The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB. | 06-10-2010 |
20110182811 | NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB - The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB. | 07-28-2011 |
Robert Serge Weil, Saint-Cloud FR
Patent application number | Description | Published |
---|---|---|
20140336126 | OPTINEURIN-DERIVED POLYPEPTIDES, THEIR NUCLEIC ACIDS AND USES THEREOF - The invention relates to Optineurin-derived polypeptide(s) consisting of a polypeptidic sequence disclosed in SEQ ID no2, which represents the portion of the wild-type human Optineurin protein sequence from its amino-acid residue 131 to its amino-acid residue 297, or having a polypeptidic sequence encompassing the polypeptidic sequence disclosed in SEQ ID no2, or having a polypeptidic sequence derived from the polypeptidic sequence disclosed in SEQ ID no2 to the exclusion of the wild-type Optineurin protein. The polypeptide(s) of the invention retain one, any combination of two, or three of the following functional properties: the capacity to bind Rab8 protein, when the latter are associated with the Golgi apparatus of a cell, the capacity to bind MYPT1 protein, when said protein is engaged in a Myosin-Phosphatase (MP) complex, the capacity to be phosphorylated by Plk1. The invention also relates to nucleic acid molecule(s) encoding such polypeptide(s), vector(s) and method(s) of production thereof, alteration(s). | 11-13-2014 |
Romain Weil, Chatuzange Le Goubet FR
Patent application number | Description | Published |
---|---|---|
20130057677 | DEVICE, KIT AND METHOD FOR INSPECTION OF AN ARTICLE - The invention relates to a device for inspecting the surface of an article having an edge with an end face, said device including: | 03-07-2013 |
Tanja Weil, Singapore SG
Patent application number | Description | Published |
---|---|---|
20110003820 | PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE - The invention relates to pyrazolopyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders. | 01-06-2011 |
20110212956 | Pyrazolopyrimidines for treating CNS disorders - Substituted pyrazolopyrimidine derivatives of formula (I) | 09-01-2011 |